LENZ
Price
$3.57
Change
+$0.14 (+4.08%)
Updated
Oct 15 closing price
Capitalization
124.42M
27 days until earnings call
Intraday BUY SELL Signals
MLTX
Price
$10.26
Change
+$0.12 (+1.18%)
Updated
Oct 15 closing price
Capitalization
983.83M
33 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LENZ vs MLTX

LENZ vs MLTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
LENZ vs. MLTX commentary
Oct 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LENZ is a Hold and MLTX is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for LENZ with price predictions
Oct 15, 2026

Momentum Indicator for LENZ turns negative, indicating new downward trend

LENZ saw its Momentum Indicator move below the 0 level on September 10, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned negative. In 77 of the 87 cases, the stock moved further down in the following days. The odds of a decline are at 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day moving average for LENZ crossed bearishly below the 50-day moving average on September 15, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 64%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LENZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

The Aroon Indicator for LENZ entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where LENZ's RSI Oscillator exited the oversold zone, 28 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for LENZ just turned positive on October 09, 2026. Looking at past instances where LENZ's MACD turned positive, the stock continued to rise in 47 of 56 cases over the following month. The odds of a continued upward trend are 84%.

Following a +5.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where LENZ advanced for three days, in 237 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 24 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.567) is normal, around the industry mean (26.782). P/E Ratio (48.030) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (5.903) is also within normal values, averaging (437.542).

The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. LENZ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LENZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for MLTX with price predictions
Oct 15, 2026

MLTX sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for MLTX moved below the 200-day moving average on September 17, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MLTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

The Aroon Indicator for MLTX entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for MLTX just turned positive on September 30, 2026. Looking at past instances where MLTX's MACD turned positive, the stock continued to rise in 42 of 55 cases over the following month. The odds of a continued upward trend are 76%.

Following a +7.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where MLTX advanced for three days, in 256 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.298) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (437.542).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. MLTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 98 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MLTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

FUNDAMENTALS RATINGS
MLTX: Fundamental Ratings
MLTX
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LENZMLTX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 4 days ago
89%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 24 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
82%
COMPARISON
Comparison
Oct 16, 2026
Stock price -- (LENZ: $3.43 vs. MLTX: $10.14)
Brand notoriety: LENZ and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LENZ: 109% vs. MLTX: 93%
Market capitalization -- LENZ: $124.42M vs. MLTX: $983.83M
LENZ [@Biotechnology] is valued at $124.42M. MLTX’s [@Biotechnology] market capitalization is $983.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LENZ’s FA Score shows that 1 FA rating(s) are green while MLTX’s FA Score has 1 green FA rating(s).

  • LENZ’s FA Score: 1 green, 4 red.
  • MLTX’s FA Score: 1 green, 4 red.
According to our system of comparison, both LENZ and MLTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LENZ’s TA Score shows that 4 TA indicator(s) are bullish while MLTX’s TA Score has 5 bullish TA indicator(s).

  • LENZ’s TA Score: 4 bullish, 5 bearish.
  • MLTX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than LENZ.

Price Growth

LENZ (@Biotechnology) experienced а -5.25% price change this week, while MLTX (@Biotechnology) price change was -5.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.58%. For the same industry, the average monthly price growth was -12.11%, and the average quarterly price growth was -18.13%.

Reported Earning Dates

LENZ is expected to report earnings on Nov 11, 2026.

MLTX is expected to report earnings on Nov 17, 2026.

Industries' Descriptions

@Biotechnology (-5.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
LENZ
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ILS20.250.04
+0.17%
Brookmont Catastrophic Bond ETF
TMFC80.490.13
+0.16%
Motley Fool 100 Index ETF (TMFC)
CPRY28.16N/A
N/A
Calamos Russell 2000 Structured Alt Protection ETF January (CPRY)
OKLS23.70N/A
N/A
Tidal Trust II Defiance Daily Target 2X Short OKLO ETF
DDLS44.53-0.06
-0.13%
WisdomTree Dynamic International SmallCap Equity Fund (DDLS)

LENZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been loosely correlated with MLTX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if LENZ jumps, then MLTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
+4.08%
MLTX - LENZ
37%
Loosely correlated
+1.18%
LKFT - LENZ
37%
Loosely correlated
+1.80%
KRYS - LENZ
36%
Loosely correlated
-0.21%
CELC - LENZ
36%
Loosely correlated
+0.67%
ANIX - LENZ
36%
Loosely correlated
+4.71%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+1.18%
KALA - MLTX
82%
Closely correlated
+3.72%
CGON - MLTX
50%
Loosely correlated
+0.03%
AUPH - MLTX
44%
Loosely correlated
+0.72%
XENE - MLTX
44%
Loosely correlated
+1.27%
AURA - MLTX
43%
Loosely correlated
+2.76%
More